133 related articles for article (PubMed ID: 7839467)
1. Orchiectomy alone for clinical stage I nonseminomatous germ cell tumors of the testis (NSGCTT): a minimum follow-up period of 5 years.
Ondrus D; Hornak M
Tumori; 1994 Oct; 80(5):362-4. PubMed ID: 7839467
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors in clinical stage I nonseminomatous germ cell testicular tumors: rationale for different risk-adapted treatment.
Ondrus D; Matoska J; Belan V; Kausitz J; Goncalves F; Hornák M
Eur Urol; 1998; 33(6):562-6. PubMed ID: 9743698
[TBL] [Abstract][Full Text] [Related]
3. Nonseminomatous germ cell testicular tumors clinical stage I: differentiated therapeutic approach in comparison with therapeutic approach using surveillance strategy only.
Ondrus D; Ondrusova M; Hornak M; Matoska J
Neoplasma; 2007; 54(5):437-42. PubMed ID: 17688374
[TBL] [Abstract][Full Text] [Related]
4. [Use of prognostic factors of disease progression in the treatment of patients with stage I nonseminomatous testicular tumors].
Ondrus D
Bratisl Lek Listy; 1999 Jan; 100(1):61-5. PubMed ID: 10493000
[TBL] [Abstract][Full Text] [Related]
5. The value of prognostic factors in the management of stage I nonseminomatous germ cell testicular tumors (NSGCTT).
Ondrus D; Goncalves F; Kausitz J; Mat'oska J; Belan V
Neoplasma; 1996; 43(3):195-7. PubMed ID: 8841507
[TBL] [Abstract][Full Text] [Related]
6. Outcomes of surveillance protocol of clinical stage I nonseminomatous germ cell tumors-is shift to risk adapted policy justified?
Divrik RT; Akdoğan B; Ozen H; Zorlu F
J Urol; 2006 Oct; 176(4 Pt 1):1424-29; discussion 1429-30. PubMed ID: 16952649
[TBL] [Abstract][Full Text] [Related]
7. Short-course adjuvant chemotherapy in high-risk stage I nonseminomatous germ cell tumors of the testis: a Medical Research Council report.
Cullen MH; Stenning SP; Parkinson MC; Fossa SD; Kaye SB; Horwich AH; Harland SJ; Williams MV; Jakes R
J Clin Oncol; 1996 Apr; 14(4):1106-13. PubMed ID: 8648364
[TBL] [Abstract][Full Text] [Related]
8. Difficulties of a surveillance study omitting retroperitoneal lymphadenectomy in clinical stage I nonseminomatous germ cell tumors of the testis.
Pizzocaro G; Zanoni F; Salvioni R; Milani A; Piva L; Pilotti S
J Urol; 1987 Dec; 138(6):1393-6. PubMed ID: 2824862
[TBL] [Abstract][Full Text] [Related]
9. Clinical stage I nonseminomatous germ cell tumors of the testis in childhood and adolescence: an analysis of 31 cases.
Terenziani M; Piva L; Spreafico F; Salvioni R; Massimino M; Luksch R; Cefalo G; Casanova M; Ferrari A; Polastri D; Mazza E; Bellani FF; Nicolai N
J Pediatr Hematol Oncol; 2002; 24(6):454-8. PubMed ID: 12218592
[TBL] [Abstract][Full Text] [Related]
10. Clinical stage I testis cancer: long-term outcome of patients on surveillance.
Sogani PC; Perrotti M; Herr HW; Fair WR; Thaler HT; Bosl G
J Urol; 1998 Mar; 159(3):855-8. PubMed ID: 9474168
[TBL] [Abstract][Full Text] [Related]
11. Surveillance can be the standard of care for stage I nonseminomatous testicular tumors and even high risk patients.
Roeleveld TA; Horenblas S; Meinhardt W; van de Vijver M; Kooi M; ten Bokkel Huinink WW
J Urol; 2001 Dec; 166(6):2166-70. PubMed ID: 11696728
[TBL] [Abstract][Full Text] [Related]
12. [Surveillance after orchiectomy for stage I testicular seminoma].
Miki T; Maeda O; Saiki S; Kinouchi T; Kuroda M; Usami M; Kotake T
Nihon Hinyokika Gakkai Zasshi; 1992 Nov; 83(11):1789-94. PubMed ID: 1479752
[TBL] [Abstract][Full Text] [Related]
13. Long-term results following adjuvant chemotherapy in patients with clinical stage I testicular nonseminomatous malignant germ cell tumors with high risk factors.
Böhlen D; Borner M; Sonntag RW; Fey MF; Studer UE
J Urol; 1999 Apr; 161(4):1148-52. PubMed ID: 10081858
[TBL] [Abstract][Full Text] [Related]
14. Long-term followup results of 1 cycle of adjuvant bleomycin, etoposide and cisplatin chemotherapy for high risk clinical stage I nonseminomatous germ cell tumors of the testis.
Westermann DH; Schefer H; Thalmann GN; Karamitopoulou-Diamantis E; Fey MF; Studer UE
J Urol; 2008 Jan; 179(1):163-6. PubMed ID: 18001800
[TBL] [Abstract][Full Text] [Related]
15. Comparative Effectiveness of Risk-adapted Surveillance vs Retroperitoneal Lymph Node Dissection in Clinical Stage I Nonseminomatous Germ Cell Testicular Cancer: A Retrospective Follow-up Study of 81 Patients.
Fan G; Zhang L; Yi L; Jiang ZQ; Ke Y; Wang XS; Xiong YY; Han WQ; Zhou X; Liu C; Yu X
Asian Pac J Cancer Prev; 2015; 16(8):3267-72. PubMed ID: 25921130
[TBL] [Abstract][Full Text] [Related]
16. Results of a policy of surveillance in stage I testicular seminoma.
Warde PR; Gospodarowicz MK; Goodman PJ; Sturgeon JF; Jewett MA; Catton CN; Richmond H; Thomas GM; Duncan W; Munro AJ
Int J Radiat Oncol Biol Phys; 1993 Sep; 27(1):11-5. PubMed ID: 8365931
[TBL] [Abstract][Full Text] [Related]
17. Risk-adapted treatment for patients with clinical stage I nonseminomatous germ cell tumor of the testis.
Amato RJ; Ro JY; Ayala AG; Swanson DA
Urology; 2004 Jan; 63(1):144-8; discussion 148-9. PubMed ID: 14751368
[TBL] [Abstract][Full Text] [Related]
18. Management of Clinical Stage I Nonseminomatous Germ Cell Testicular Tumors: A 25-year Single-center Experience.
Ondrusova M; Waczulikova I; Lehotska V; Zeleny T; Ondrus D
Clin Genitourin Cancer; 2017 Dec; 15(6):e1015-e1019. PubMed ID: 28673797
[TBL] [Abstract][Full Text] [Related]
19. Controversies in the management of clinical stage I nonseminomatous germ cell testicular cancer.
Ondrus D; Kajo K; Stastna V; Ondrusova M
Klin Onkol; 2015; 28(2):112-5. PubMed ID: 25882021
[TBL] [Abstract][Full Text] [Related]
20. Early clinical stages of nonseminomatous testis cancer. Evaluation of the primary treatment and follow-up procedures of the SWENOTECA project.
Klepp O; Olsson AM; Ous S; Nilsson S; Høisaether PA; Tveter K
Scand J Urol Nephrol; 1991; 25(3):179-90. PubMed ID: 1658924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]